Similarly, RUNX3 is frequently inactivated in human atypical adenomatous hyperplasia (AAH) and bronchioloalveolar carcinoma (BAC), which correspond to mouse lung ADs, and inactivation of Runx3 induces lung ADs in mice [19]. Here, RUNX3 is linked to bronchioloalveolar carcinoma.